NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions declared that its Board of Directors has initiated a stock buyback program on Thursday, August 2nd 2018, which authorizes the company to buyback $250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 11.3% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) posted its quarterly earnings results on Thursday, May, 2nd. The software maker reported $0.16 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.14 by $0.02. The software maker had revenue of $432 million for the quarter, compared to the consensus estimate of $436.47 million. Allscripts Healthcare Solutions had a return on equity of 6.92% and a net margin of 20.60%. The company's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.16 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions updated its FY19 earnings guidance on Thursday, May, 2nd. The company provided EPS guidance of $0.65 to $0.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.67. Allscripts Healthcare Solutions also updated its FY 2019 guidance to $0.65-0.70 EPS.

9 brokers have issued 12-month price targets for Allscripts Healthcare Solutions' shares. Their forecasts range from $10.00 to $16.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $13.2857 in the next twelve months. This suggests a possible upside of 27.7% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.

Media stories about MDRX stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Allscripts Healthcare Solutions earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned media stories about the software maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future.

Allscripts Healthcare Solutions saw a increase in short interest during the month of April. As of April 15th, there was short interest totalling 20,675,861 shares, an increase of 8.4% from the March 29th total of 19,078,421 shares. Based on an average trading volume of 1,566,012 shares, the days-to-cover ratio is currently 13.2 days. Approximately 12.4% of the shares of the stock are short sold. View Allscripts Healthcare Solutions' Current Options Chain.

Some companies that are related to Allscripts Healthcare Solutions include Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE), Tufin Software Technologies (TUFN), Digimarc (DMRC), Onespan (OSPN), KEYW (KEYW), Ribbon Communications (RBBN), Unisys (UIS) and Pareteum (TEUM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Starbucks (SBUX), Walgreens Boots Alliance (WBA), Electronic Arts (EA), Nuance Communications (NUAN), AK Steel (AKS), Bausch Health Companies (BHC), Twitter (TWTR) and Autodesk (ADSK).

Allscripts Healthcare Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.56%), Neuberger Berman Group LLC (1.88%), Northern Trust Corp (1.59%), Geode Capital Management LLC (1.56%), Fort Washington Investment Advisors Inc. OH (0.90%) and Jacobs Levy Equity Management Inc. (0.86%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Fort Washington Investment Advisors Inc. OH, Royce & Associates LP, Dimensional Fund Advisors LP, Marshall Wace LLP, BNP Paribas Arbitrage SA, Hennessy Advisors Inc. and Dupont Capital Management Corp. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Alambic Investment Management L.P., Penn Capital Management Co. Inc., Man Group plc, Neuberger Berman Group LLC, GAM Holding AG, SEI Investments Co, Dynamic Technology Lab Private Ltd and Peregrine Capital Management LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDRX stock can currently be purchased for approximately $10.40.

Allscripts Healthcare Solutions has a market capitalization of $1.73 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]